MeiraGTx Holdings plc
MGTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001735438
In the last 90 days, MeiraGTx Holdings plc insiders filed 0 open-market purchases and 3 sales; 158 institutions reported holding it in 13F filings for Q2 2026, worth $1.07B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in MeiraGTx Holdings plc as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 118
- +17 vs. Q4 2024
- Shares held
- 60.0M
- +2.04M (+3.5%) vs. Q4 2024
- Total value
- $406.7M
- +$53.9M (+15.3%) vs. Q4 2024
- New holders
- 22
- 43 more added
- Sold out
- 5
- 34 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 158 | $1.07B |
| Q1 2026 | 133 | $583.0M |
| Q4 2025 | 130 | $518.2M |
| Q3 2025 | 123 | $527.6M |
| Q2 2025 | 112 | $419.6M |
| Q1 2025 | 118 | $406.7M |
| Q4 2024 | 102 | $353.9M |
| Q3 2024 | 99 | $188.6M |
| Q2 2024 | 95 | $170.4M |
| Q1 2024 | 96 | $238.5M |
| Q4 2023 | 86 | $275.1M |
| Q3 2023 | 75 | $185.6M |
| Q2 2023 | 79 | $253.6M |
| Q1 2023 | 92 | $148.6M |
| Q4 2022 | 99 | $193.0M |
| Q3 2022 | 100 | $234.5M |
| Q2 2022 | 108 | $216.1M |
| Q1 2022 | 103 | $405.7M |
| Q4 2021 | 99 | $672.9M |
| Q3 2021 | 81 | $367.3M |
| Q2 2021 | 80 | $433.5M |
| Q1 2021 | 81 | $384.8M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding MeiraGTx Holdings plc; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Invesco Ltd. | 350,401 | $2.38M | 0.00% | +330,131+1,628.7% | Added |
| Dimensional Fund Advisors LP | 392,398 | $2.66M | 0.00% | −6,415−1.6% | Reduced |
| Vanguard Group Inc | 449,549 | $3.05M | 0.00% | −9,367−2.0% | Reduced |
| Geode Capital Management, LLC | 597,903 | $4.05M | 0.00% | +27,257+4.8% | Added |
| Royce & Associates LP | 607,839 | $4.12M | 0.04% | −2,436−0.4% | Reduced |
| State Street Corp | 644,086 | $4.37M | 0.00% | +41,796+6.9% | Added |
| Erste Asset Management GmbH | 789,702 | $5.37M | 0.07% | +120,000+17.9% | Added |
| Woodline Partners LP | 803,546 | $5.45M | 0.04% | −731,578−47.7% | Reduced |
| J. Goldman & Co LP | 1,158,761 | $7.86M | 0.28% | +608,241+110.5% | Added |
| Knoll Capital Management, LLC | 1,250,000 | $8.47M | 5.51% | 00.0% | Unchanged |
| Rubric Capital Management LP | 1,776,321 | $12.0M | 0.22% | +1,776,321 | New |
| 683 Capital Management, LLC | 2,575,000 | $17.5M | 1.77% | +160,000+6.6% | Added |
| BlackRock, Inc. | 3,128,405 | $21.2M | 0.00% | +156,881+5.3% | Added |
| Prosight Management, LP | 3,691,546 | $25.0M | 8.22% | −699,291−15.9% | Reduced |
| Adage Capital Partners GP, L.L.C. | 5,634,578 | $38.2M | 0.07% | +600,000+11.9% | Added |
| Johnson & Johnson | 6,641,064 | $45.0M | 13.17% | 00.0% | Unchanged |
| Sanofi | 12,197,737 | $82.7M | 49.84% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 12,581,103 | $85.3M | 3.02% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −330,182−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −48,855−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −46,370−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −18,040−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −12,338−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |